8078 Inorg. Chem. 2009, 48, 8078–8080
DOI: 10.1021/ic9013653
Stability of a Ferryl-Peptide Conjugate Is Controlled by a Remote Substituent
Nitinkumar D. Jabre, Lew Hryhorczuk, and Jeremy J. Kodanko*
Department of Chemistry and Central Instrumentation Facility, Wayne State University, 5101 Cass Avenue,
Detroit, Michigan 48202
Received July 13, 2009
The formation of a synthetic ferryl-peptide conjugate and me-
chanistic studies that elucidate its mode of decomposition are
presented. A ferryl species is generated from a ligand-dipeptide
conjugate 4. The ferryl species [FeIV(4)(O)]2þ, noted as com-
pound 5, was characterized by UV-vis spectroscopy and by high-
resolution electrospray mass spectrometry. The ferryl-peptide
conjugate 5 is stable for over 1 h at room temperature. Ester
derivatives of 5 decay at different rates, consistent with the remote
ester group controlling the stability of the ferryl. The kinetic isotope
effect value (4.5) and F = -1.3 observed with ester derivatives
suggest that the mechanism for decomposition of 5 follows a
hydrogen-atom-transfer pathway. The formation and decay of 5
was fit to a two-step process, with the decay being unimolecular
with respect to the ferryl 5.
artifical oxygenases that generate ferryl species. In this
Communication, we report the interesting observation that
the stability of a ferryl-peptide conjugate can be controlled
by a remote functional group that is 11 atoms removed from
the iron center. In addition, reported mechanistic studies
support an intramolecular decay pathway for the ferryl-
peptide conjugate.
In order to synthesize the ferryl-peptide conjugate, syn-
thetic methodology was developed for attaching pentaden-
tate ligands like N4Py to an alanine side chain. Toward this
goal, the unnatural amino acid 2, hydroxymethylpyridylala-
nine (HPA), was synthesized in racemic form in two steps
starting from bromide 1 using phase-transfer alkylation as
the key step (Scheme 1).9 After acetylation, the unnatural
amino acid was incorporated into dipeptide 3 upon coupling
with H-Gly-OBn. Attaching the remainder of the metal-
binding group was accomplished by transforming the sily-
loxy group of 3 into a chloride, followed by displacement
with the secondary amine NH(CH2Py)(CHPy2) (where Py=
2-pyridyl). Installation of the metal-binding unit in the last
step was ideal because it maximized the divergence of the
synthesis. Furthermore, this approach holds the advantage
that the amino acid 2 can be placed at varied positions along a
peptide chain.
To form the ferrous complex of the peptide, a solution of 4 in
H2O/CH3CN (1:1) was treated with 1 equiv of FeII(ClO4)2 to
generate the species in situ. Spectral data for [FeII(4)-
(CH3CN)]2þ are in good agreement with those for the parent
ligand N4Py in the same solvent mixture (Table S1 in the
Supporting Information, SI). The complex [FeII(4)(CH3-
CN)]2þ was characterized by UV-vis (ε380=4200 M-1 cm-1
and ε455=3600 M-1 cm-1) and NMR spectroscopy, as well as
by electrospray mass spectrometry (ESMS; Figures S1 and
S2 in the SI). All resonances in the NMR spectrum of
[FeII(4)(CH3CN)]2þ lie between 10 and 0 ppm, consistent with
the ferrous complex being in the low-spin state.
High-valent iron(IV) oxo species, also known as ferryls,
are found in enzymes that carry out oxidation reactions in
nature.1,2 Ligands that mimic the active sites of these enzymes
can be used to generate biomimetic ferryl species3,4 that
oxidize a variety of organic molecules in an intermolecular
fashion.5,6 In contrast, reactions of ferryls tethered to organic
substrates have received little attention.7,8 In fact, it is not
currently understood which functional groups are compati-
ble with a ferryl in a complex molecule. This is unfortunate
because these data are relevant to the understanding of which
functionalities would be tolerated in synthetic catalysts or
*To whom correspondence should be addressed. E-mail: jkodanko@
chem.wayne.edu.
(1) Krebs, C.; Fujimori, D. G.; Walsh, C. T.; Bollinger, J. M. Jr. Acc.
Chem. Res. 2007, 40, 484–492.
(2) Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L. Jr. Chem. Rev. 2004,
104, 939–986.
(3) Que, L. Acc. Chem. Res. 2007, 40, 493–500.
(4) Nam, W. Acc. Chem. Res. 2007, 40, 522–531.
(5) Kaizer, J.; Klinker, E. J.; Oh, N. Y.; Rohde, J.-U.; Song, W. J.;
::
The ferrous complex [FeII(4)(CH3CN)]2þ was used to
generate a ferryl with impressive stability, considering the
weak C-H bonds present in the peptide placed in close proxi-
mity to the iron center. Treatment of [FeII(4)(CH3CN)]2þ
with KHSO5 at 25 °C generated a pale-green species, noted
as compound 5, with a maximum absorption wavelength at
Stubna, A.; Kim, J.; Munck, E.; Nam, W.; Que, L. Jr. J. Am. Chem. Soc.
2004, 126, 472–473.
(6) van den Berg, T. A.; de Boer, J. W.; Browne, W. R.; Roelfes, G.;
Feringa, B. L. Chem. Commun. 2004, 2550–2551.
(7) Jensen, M. P.; Lange, S. J.; Mehn, M. P.; Que, E. L.; Que, L. Jr. J. Am.
Chem. Soc. 2003, 125, 2113–2128.
(8) For characterization of an FeIII(OOH) species derived from N4Py
bound to a peptide, see: (a) Choma, C. T.; Schudde, E. P.; Kellogg, R. M.;
Robillard, G. T.; Feringa, B. L. J. Chem. Soc., Perkin Trans. 1 1998, 769–774.
(b) van den Heuvel, M.; van den Berg, T. A.; Kellogg, R. M.; Choma, C. T.;
Feringa, B. L. J. Org. Chem. 2004, 69, 250–262.
(9) The enantioselective synthesis of 2 will be reported elsewhere.
r
pubs.acs.org/IC
Published on Web 07/31/2009
2009 American Chemical Society